PDE7 inhibitors (BrainCo)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NamePDE7 inhibitors (BrainCo)

Drug Alias NameIMBCo-010PDE7 inhibitors (BrainCo)IMBCo-020S-14 (CSIC)small molecule therapeutics for multiple sclerosis(Medicinal Chemistry Institute of CSIC)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPhosphodiesterase 7 inhibitors

TargetsPhosphodiesterase 7

Therapy Area/IndicationsMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSpanish National Research Council

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBrainco Biopharma Sl

Active IndicationsN/A

Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A